从困惑到豁然hap流调学习体会福州周华.pptVIP

肠杆菌科细菌的抗生素耐药 刘又宁 中国16家大型教学医院HAP临床调查 头孢哌酮/舒巴坦对产ESBLs菌抗菌活性 8％ 2 18％ 4 30％ 8 17% 16 15% 32 10% 耐药 3.0 Q12h 3.0 Q8h HAP的治疗 HAP的治疗 HAP的治疗 * Take home HAP关键在于判断可能病原体及耐药性，流调结果可指导HAP经验性治疗 合格呼吸道标本对HAP诊断、治疗有指导作用 HAP治疗要重视非发酵菌和MRSA 头孢哌酮/舒巴坦可以较好覆盖HAP主要致病菌、利奈唑胺是MRSA肺炎的最佳选择 * * Although noninvasive ventilation (NIV) use in severe acute exacerbation of COPD has substantially reduced the need for intubation, an important number of COPD patients still are mechanically ventilated through a tracheal tube in the ICU. Intubation is a major risk factor for lower respiratory tract colonization (LRTC) in ICU patients.